At 8.3% CAGR, the Europe Deep Brain Simulation Market is Projected to be worth US$ 319.88 million by 2030, says Business Market Insights

According to Business Market Insights research, the Europe deep brain simulation market was valued at US$ 169.14 million in 2022 and is expected to reach US$ 319.88 million by 2030, registering a CAGR of 8.3% from 2022 to 2030. Rising prevalence of neurological disorders and increasing demand for minimally invasive surgery are the critical factors attributed to the Europe deep brain simulation market expansion.

The geriatric population is susceptible to neurological diseases. Neuropathy, Parkinson's disease, Alzheimer's disease, and dystonia are among the most common neurological disorders affecting older people. High mortality and disease burden necessitate the clinical urgency for integrating long-term solutions such as deep brain stimulators (DBS). Therefore, growing awareness regarding the burden of neurological disorders, the growing geriatric population, and the increasing prevalence of neurological diseases propel the demand for deep brain stimulators as a therapy.  

On the contrary, side effects associated with deep brain stimulation hurdles the growth of Europe deep brain simulation market.

Based on product, the Europe deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. The dual channel deep brain stimulator segment held 49.5% share of Europe deep brain simulation market in 2023, amassing US$ 83.77 million. It is projected to garner US$ 170.93 million by 2030 to expand at 9.3% CAGR during 2022–2030.

Based on application, the Europe deep brain simulation market is segmented into Parkinson’s disease, tremor, dystonia, epilepsy, Alzheimer’s disease, and others. The Parkinson’s disease segment held 69.3% share of Europe deep brain simulation market in 2023, amassing US$ 140.84 million. It is projected to garner US$ 267.21 million by 2030 to expand at 8.3% CAGR during 2022–2030.

Based on end user, the Europe deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. The hospitals segment held 56.4% share of Europe deep brain simulation market in 2022, amassing US$ 95.46 million. It is projected to garner US$ 188.97 million by 2030 to expand at 8.9% CAGR during 2022–2030.  

Based on country, the Europe deep brain simulation market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 24.7% share of Europe deep brain simulation market in 2022. It was assessed at US$ 41.73 million in 2022 and is likely to hit US$ 81.51 million by 2030, exhibiting a CAGR of 8.7% during 2022–2030.

Key players operating in the Europe deep brain simulation market report Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corp, Medtronic Plc, and Newronika SpA, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com